Atrial fibrillation medical therapy in patients presenting with ACS and/or PCI or valve intervention

Revision as of 17:51, 4 September 2014 by Rim Halaby (talk | contribs) (Created page with "__NOTOC__ {| class="infobox" style="float:right;" |- | 30px|link=Atrial fibrillation resident survival guide|| <br> || <br> | Atrial fibrillation resident...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search


Resident
Survival
Guide

Atrial Fibrillation Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Atrial Fibrillation from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Special Groups

Postoperative AF
Acute Myocardial Infarction
Wolff-Parkinson-White Preexcitation Syndrome
Hypertrophic Cardiomyopathy
Hyperthyroidism
Pulmonary Diseases
Pregnancy
ACS and/or PCI or valve intervention
Heart failure

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

EKG Examples
A-Fib with LBBB

Chest X Ray

Echocardiography

Holter Monitoring and Exercise Stress Testing

Cardiac MRI

Treatment

Rate and Rhythm Control

Cardioversion

Overview
Electrical Cardioversion
Pharmacological Cardioversion

Anticoagulation

Overview
Warfarin
Converting from or to Warfarin
Converting from or to Parenteral Anticoagulants
Dabigatran

Maintenance of Sinus Rhythm

Surgery

Catheter Ablation
AV Nodal Ablation
Surgical Ablation
Cardiac Surgery

Specific Patient Groups

Primary Prevention

Secondary Prevention

Supportive Trial Data

Cost-Effectiveness of Therapy

Case Studies

Case #1

Atrial fibrillation medical therapy in patients presenting with ACS and/or PCI or valve intervention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Atrial fibrillation medical therapy in patients presenting with ACS and/or PCI or valve intervention

CDC on Atrial fibrillation medical therapy in patients presenting with ACS and/or PCI or valve intervention

Atrial fibrillation medical therapy in patients presenting with ACS and/or PCI or valve intervention in the news

Blogs on Atrial fibrillation medical therapy in patients presenting with ACS and/or PCI or valve intervention

Directions to Hospitals Treating Atrial fibrillation medical therapy in patients presenting with ACS and/or PCI or valve intervention

Risk calculators and risk factors for Atrial fibrillation medical therapy in patients presenting with ACS and/or PCI or valve intervention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Overview

==2014 Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of EHRA, EAPCI, ACCA endorsed by HRS and APHRS (DO NOT EDIT)[1]==

References

  1. Task Force Members. Lip GY, Windecker S, Huber K, Kirchhof P, Marin F; et al. (2014). "Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)". Eur Heart J. doi:10.1093/eurheartj/ehu298. PMID 25154388.


Template:WikiDoc Sources